IN Capital strives to become the leading healthcare investment firm in China
Hong Ying
Venture Partner

Mr. Hong is the COO of Genetron and more than 20 years of experience in medical device market operations. He is the former Bard China CEO and Northern Asia VP and J&J Medical Asia market director. He led and managed Bard's five operating departments in China, Hong Kong, Taiwan and South Korea. The product covers the areas of surgery, cancer, radiation intervention, peripheral vessels, maternity, biopsy and urination.

Copyright © In Capital 2019